UTMD Earnings

Quarterly EPS
$1.02
Q3 2024
$0.86
Q4 2024
$0.92
Q1 2025
$0.94
Q2 2025
$0.82
Q3 2025
$0.80
Q4 2025
$0.82
Q1 2026
$0.84
Q2 2026
Latest Revenue8.5M
Latest Net Income2.7M
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026$0.848.5M2.7M-14.3%-10.6%
Q1 2026$0.828.7M2.6M-10.2%-10.9%
Q4 2025$0.809.0M2.6M-1.2%-7.0%
Q3 2025$0.829.8M2.6M-1.9%-19.6%
Q2 2025$0.9410.0M3.0M-4.3%-4.1%
Q1 2025$0.929.7M3.0M-14.4%-15.6%
Q4 2024$0.869.2M2.9M-25.7%-27.1%
Q3 2024$1.0210.0M3.6M-20.0%-5.6%
Q2 2024$0.9810.4M3.5M
Q1 2024$1.0911.3M4.0M
Q4 2023$1.1812.3M4.3M
Q3 2023$1.0812.5M3.9M
Utah Medical Products (UTMD) — Earnings